NCT07291336 Comparing Dynamic Navigation to Static Navigation in the Implant Placement
| NCT ID | NCT07291336 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Ain Shams University |
| Condition | Healthy Adults |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 20 participants in total. It began in 2022-10-01 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Implant placement is preplanned by taking xrays and impressions for the mouth one group a guide is fabricated and used to guide the implant drilling all through to the implant placement the other group, no guide is fabricated, but the implant is placed by dynamic navigation through looking in a screen and checking where the implant is fully placed
Eligibility Criteria
Inclusion Criteria: * Healthy patients at least 22 years old. * At least one missing tooth to be restored using an implant in the upper jaw from the maxillary right 2nd premolar to the maxillary left 2nd premolar. * At least six residual teeth in the affected jaw (5). * Minimum of 5 mm available bone. Exclusion Criteria: * Medical condition or medication that would impair bone healing. * Poor oral hygiene * Inadequate bone width or height that may need bone augmentation. 5 * Alcohol users. * Smoking more than 10 cigarettes per day. * History of head and neck radiotherapy. * Pregnant females. * Uncontrolled hypertensive or diabetic patient. * Vulnerable group; prisoners, pregnant women, orphans…etc
Frequently Asked Questions
Who can join the NCT07291336 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, up to 60 Years, studying Healthy Adults. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07291336 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07291336 currently recruiting?
Yes, NCT07291336 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ain Shams University to inquire about joining.
Where is the NCT07291336 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07291336 clinical trial?
NCT07291336 is sponsored by Ain Shams University. The trial plans to enroll 20 participants.